skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Analysis of Average Royalty Rates in Pharma by Phase and Therapy Area. Royalty payments are an essential component of most pharmaceutical deals. Along with upfront payments and milestones, companies are rewarded for surpassing certain developmental hurdles. A properly structured deal will achieve a balance among these financial payment types. This begs the question of what is the proper royalty rate to be paid to the product owner or originator. In order to address this, an analysis of historical royalty rates in the pharmaceutical sector was assembled using Medtrack®’s Royalty Analyzer.

Maximizing Royalty Rate Opportunities in Pharma Licensing

Medtrack®, a leading provider of pharmaceutical and commercial intelligence information, follows nearly 32,000 pharmaceutical, biotechnology and medical device companies, 124,000 drugs (including generics) spanning 2,100 indications, and 105,000 deals including partnerships. 
Maximizing Royalty Rate Opportunities in Pharma Licensing

Read also

  • Medtech Insight: global medical technology news & analysis

    Pre-MDR Predictions and What You Can Expect

    Updates to the EU Medical Devices Regulation are just weeks away from becoming a reality for manufacturers and suppliers. Medtech Insight delivers expert insights into the latest developments and what they could mean for your business.

    Topics Medtech

  • Medtech Insight: global medical technology news & analysis

    Medtech Deal-Making Round Up

    Keep current with comprehensive coverage of today’s deals and their impact on the future of the medtech landscape. Medtech Insight brings you insight and analysis of significant recent deals and what they mean for your strategy. Stay in the know with your free Quarterly Roundup.

    Topics Medtech

  • Medtech Insight: global medical technology news & analysis

    US Administrations and Medtech Industry: An International Focus

    As the US embarks on a new era in leadership, changes in regulatory, policy, manufacturing and supply chains of medical devices and diagnostics will take place. What changes in the US medtech market can we expect to see over the next four years?

    Topics Medtech

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: